Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
A KCK pharmaceutical company gets a cash injection that should sustain it long enough to get an ADHD drug to the FDA for ...
Yahoo Finance4d
Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
KANSAS CITY, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
Nasdaq4d
Cingulate Inc. Secures $5 Million Financing to Support Pharmaceutical Development Initiatives
Cingulate Inc. secures $5 million in financing to support clinical and operational activities, targeting NDA filing for CTx-1301 by mid-2025. Cingulate Inc. has secured $5 million in net proceeds ...